ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 135 filers reported holding ANIKA THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $250,000 | -56.5% | 7,804 | -41.1% | 0.00% | -50.0% |
| Q1 2017 | $575,000 | -0.7% | 13,245 | +11.9% | 0.00% | 0.0% |
| Q4 2016 | $579,000 | +22.9% | 11,835 | +12.4% | 0.00% | 0.0% |
| Q1 2016 | $471,000 | -15.6% | 10,530 | -37.6% | 0.00% | +100.0% |
| Q2 2015 | $558,000 | +0.4% | 16,882 | +23.8% | 0.00% | -50.0% |
| Q4 2014 | $556,000 | -72.8% | 13,638 | -75.5% | 0.00% | -75.0% |
| Q3 2014 | $2,042,000 | -19.6% | 55,701 | +1.5% | 0.01% | -27.3% |
| Q2 2014 | $2,541,000 | -18.8% | 54,853 | -27.9% | 0.01% | -21.4% |
| Q1 2014 | $3,129,000 | +769.2% | 76,124 | +706.2% | 0.01% | +600.0% |
| Q4 2013 | $360,000 | -4.5% | 9,442 | -40.2% | 0.00% | 0.0% |
| Q3 2013 | $377,000 | +53.3% | 15,801 | +9.1% | 0.00% | 0.0% |
| Q2 2013 | $246,000 | – | 14,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Portolan Capital Management | 217,105 | $10,058,000 | 2.20% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 284,393 | $13,175,000 | 0.88% |
| AMI ASSET MANAGEMENT CORP | 183,494 | $8,501,000 | 0.84% |
| CAPITAL MANAGEMENT CORP /VA | 49,765 | $2,306,000 | 0.74% |
| TFS CAPITAL LLC | 105,839 | $4,904,000 | 0.39% |
| Baltimore-Washington Financial Advisors, Inc. | 24,390 | $1,130,000 | 0.35% |
| OBERWEIS ASSET MANAGEMENT INC/ | 27,600 | $1,279,000 | 0.32% |
| Stephens Investment Management Group LLC | 192,650 | $8,925,000 | 0.27% |
| THOMPSON SIEGEL & WALMSLEY LLC | 263,622 | $12,214,000 | 0.24% |
| DIKER MANAGEMENT LLC | 21,200 | $982,000 | 0.22% |